Recent Finacing
Recent Raise
Immune Regulation is a clinical-stage US/UK biotechnology company developing short‑PK immune-resetting therapies (IRL201805, IRL201104) that shift immunity from pro‑inflammatory to regulatory to induce long‑term remission.
